Thuja Capital adds Dr. Herbert Heyneker to its Scientific Advisory Board

Date: 13/11/2008

Utrecht, The Netherlands – Thuja Capital is happy to announce that Herbert Heyneker has accepted to join its Scientific Advisory Board.

Dr. Heyneker has a long track record, as molecular biologist and industrial scientist who was actively involved in the development of the first recombinant proteins while working at the basis of Genentech, and as an entrepreneur co-founding several biotechnology companies. In his role as entrepreneur and moreover as advisor to venture capital firm Abingworth, Herb has gained hands-on experience and knowledge of life sciences investing.

Michel Briejer, Investor Director and partner of Thuja Capital, comments: “Herb is a great addition to our Scientific Advisory Board. Given his track record and highly relevant experience and international network he can further help us to make our funds successful.”